ShiLai™ Healthcare — Peptide Manufacturer & Retatrutide OEM

Peptide Portfolio

Emerging & Novel Peptides

ShiLai™ Healthcare manufactures emerging and novel peptides for B2B OEM and research partners. Our CDMO capability supports custom synthesis of new peptide sequences, including peptides not yet in our standard catalogue. Contact us to discuss feasibility and timelines.

Enquire About Custom Synthesis

Custom Peptide Synthesis

ShiLai™ Healthcare's CDMO team evaluates custom peptide synthesis requests on a project-by-project basis. Submit your peptide sequence, target purity, quantity, and delivery format and our technical team will assess feasibility and provide a quotation.

We have established synthesis processes for peptides up to 50+ amino acids, including modified, cyclic, and conjugated peptides. Contact us to discuss your specific requirements.

Recently Added Peptides

Retatrutide (GLP-1/GIP/Glucagon triple agonist)
Eloralintide (CGRP antagonist)
MOTS-c (Mitochondrial-derived peptide)
SS-31 (Elamipretide)
Kisspeptin-10
KPV (alpha-MSH fragment)
LL-37 (Cathelicidin)
Epitalon

B2B OEM Projects Only

We are currently not accepting individual or retail customer orders.

Chat on WhatsApp

Related Pages